BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23519781)

  • 41. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal and postnatal findings in serpentine fibula polycystic kidney syndrome and a review of the NOTCH2 spectrum disorders.
    Martin BM; Ivanova MH; Sarukhanov A; Kim A; Power P; Pugash D; Popescu OE; Lachman RS; Krakow D; Patel MS
    Am J Med Genet A; 2014 Oct; 164A(10):2490-5. PubMed ID: 24995648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signaling pathways affecting skeletal health.
    Marie PJ
    Curr Osteoporos Rep; 2012 Sep; 10(3):190-8. PubMed ID: 22711369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.
    Irie N; Takada Y; Watanabe Y; Matsuzaki Y; Naruse C; Asano M; Iwakura Y; Suda T; Matsuo K
    J Biol Chem; 2009 May; 284(21):14637-44. PubMed ID: 19299512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Notch signaling in postnatal joint chondrocytes, but not subchondral osteoblasts, is required for articular cartilage and joint maintenance.
    Liu Z; Ren Y; Mirando AJ; Wang C; Zuscik MJ; O'Keefe RJ; Hilton MJ
    Osteoarthritis Cartilage; 2016 Apr; 24(4):740-51. PubMed ID: 26522700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Boning up on ephrin signaling.
    Mundy GR; Elefteriou F
    Cell; 2006 Aug; 126(3):441-3. PubMed ID: 16901775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.
    Iacobini C; Blasetti Fantauzzi C; Bedini R; Pecci R; Bartolazzi A; Amadio B; Pesce C; Pugliese G; Menini S
    Metabolism; 2018 Jun; 83():149-158. PubMed ID: 29432728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth.
    Mosig RA; Dowling O; DiFeo A; Ramirez MC; Parker IC; Abe E; Diouri J; Aqeel AA; Wylie JD; Oblander SA; Madri J; Bianco P; Apte SS; Zaidi M; Doty SB; Majeska RJ; Schaffler MB; Martignetti JA
    Hum Mol Genet; 2007 May; 16(9):1113-23. PubMed ID: 17400654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoblast lineage-specific effects of notch activation in the skeleton.
    Canalis E; Parker K; Feng JQ; Zanotti S
    Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Notch signaling promotes osteoclast maturation and resorptive activity.
    Ashley JW; Ahn J; Hankenson KD
    J Cell Biochem; 2015 Nov; 116(11):2598-609. PubMed ID: 25914241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calmodulin-an often-ignored signal in osteoclasts.
    Williams JP; Micoli K; McDonald JM
    Ann N Y Acad Sci; 2010 Mar; 1192(1):358-64. PubMed ID: 20392260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hajdu-Cheney syndrome: a review.
    Canalis E; Zanotti S
    Orphanet J Rare Dis; 2014 Dec; 9():200. PubMed ID: 25491639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fracture healing in a mouse model of Hajdu-Cheney-Syndrome with high turnover osteopenia results in decreased biomechanical stability.
    Ballhause TM; Jiang S; Xie W; Sevecke J; Dowling C; Dust T; Brandt S; Mertens PR; Yorgan TA; Schinke T; Frosch KH; Baranowsky A; Keller J
    Sci Rep; 2023 Jul; 13(1):11418. PubMed ID: 37452111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoclast-derived coupling factors in bone remodeling.
    Henriksen K; Karsdal MA; Martin TJ
    Calcif Tissue Int; 2014 Jan; 94(1):88-97. PubMed ID: 23700149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MAGED1 is a negative regulator of bone remodeling in mice.
    Liu M; Xu L; Ma X; Xu J; Wang J; Xian M; Zhou X; Wang M; Wang F; Qin A; Pan Q; Wen C
    Am J Pathol; 2015 Oct; 185(10):2653-67. PubMed ID: 26272363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation.
    Hilton MJ; Tu X; Wu X; Bai S; Zhao H; Kobayashi T; Kronenberg HM; Teitelbaum SL; Ross FP; Kopan R; Long F
    Nat Med; 2008 Mar; 14(3):306-14. PubMed ID: 18297083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rheumatoid Arthritis in the View of Osteoimmunology.
    Auréal M; Machuca-Gayet I; Coury F
    Biomolecules; 2020 Dec; 11(1):. PubMed ID: 33396412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mice harboring a Hajdu Cheney Syndrome mutation are sensitized to osteoarthritis.
    Zanotti S; Yu J; Bridgewater D; Wolf JM; Canalis E
    Bone; 2018 Sep; 114():198-205. PubMed ID: 29940267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.